342 related articles for article (PubMed ID: 26270441)
1. Prognostic Value of Ki-67 Labeling Index and Postoperative Radiotherapy in WHO Grade II Meningioma.
Choi Y; Lim DH; Yu JI; Jo K; Nam DH; Seol HJ; Lee JI; Kong DS; Suh YL; Nam H
Am J Clin Oncol; 2018 Jan; 41(1):18-23. PubMed ID: 26270441
[TBL] [Abstract][Full Text] [Related]
2. Analysis of patterns of failure and appraisal of postoperative radiation field for grade II-III meningioma.
Lee JJB; Lee J; Yoon HI; Kim SH; Cho J; Lee KS; Chang JH; Suh CO
J Neurooncol; 2019 Sep; 144(2):333-341. PubMed ID: 31278690
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
4. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
5. World Health Organization Grade II Meningioma: A 10-Year Retrospective Study for Recurrence and Prognostic Factor Assessment.
Champeaux C; Dunn L
World Neurosurg; 2016 May; 89():180-6. PubMed ID: 26850975
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant radiotherapy for atypical meningiomas.
Bagshaw HP; Burt LM; Jensen RL; Suneja G; Palmer CA; Couldwell WT; Shrieve DC
J Neurosurg; 2017 Jun; 126(6):1822-1828. PubMed ID: 27611201
[TBL] [Abstract][Full Text] [Related]
7. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.
Bruna J; Brell M; Ferrer I; Gimenez-Bonafe P; Tortosa A
Neuropathology; 2007 Apr; 27(2):114-20. PubMed ID: 17494511
[TBL] [Abstract][Full Text] [Related]
8. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.
Korshunov A; Shishkina L; Golanov A
Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057
[TBL] [Abstract][Full Text] [Related]
9. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.
Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T
J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572
[TBL] [Abstract][Full Text] [Related]
10. Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute.
Weber DC; Schneider R; Goitein G; Koch T; Ares C; Geismar JH; Schertler A; Bolsi A; Hug EB
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):865-71. PubMed ID: 22138457
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
[TBL] [Abstract][Full Text] [Related]
12. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection.
Mizrachi M; Hartley B; Saleem S; Hintz E; Ziemba Y; Li J; Goenka A; Schulder M
J Clin Neurosci; 2024 Jun; 124():15-19. PubMed ID: 38631196
[TBL] [Abstract][Full Text] [Related]
13. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
[TBL] [Abstract][Full Text] [Related]
14. Relationship between malignant subtypes of meningioma and clinical outcome.
Ko KW; Nam DH; Kong DS; Lee JI; Park K; Kim JH
J Clin Neurosci; 2007 Aug; 14(8):747-53. PubMed ID: 17499508
[TBL] [Abstract][Full Text] [Related]
15. Survival and failure patterns in atypical and anaplastic meningiomas: A single-center experience of surgery and postoperative radiotherapy.
Kumar N; Kumar R; Khosla D; Salunke PS; Gupta SK; Radotra BD
J Cancer Res Ther; 2015; 11(4):735-9. PubMed ID: 26881510
[TBL] [Abstract][Full Text] [Related]
16. Intracranial meningeal hemangiopericytoma: 10 years experience of a tertiary care Institute.
Kumar N; Kumar R; Kapoor R; Ghoshal S; Kumar P; Salunke PS; Radotra BD; Sharma SC
Acta Neurochir (Wien); 2012 Sep; 154(9):1647-51. PubMed ID: 22790838
[TBL] [Abstract][Full Text] [Related]
17. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
[TBL] [Abstract][Full Text] [Related]
18. Surgery for convexity meningioma: Simpson Grade I resection as the goal: clinical article.
Hasseleid BF; Meling TR; Rønning P; Scheie D; Helseth E
J Neurosurg; 2012 Dec; 117(6):999-1006. PubMed ID: 23061394
[TBL] [Abstract][Full Text] [Related]
19. Early postoperative radiotherapy improves progression free survival in patients with grade 2 meningioma.
Aboukais R; Baroncini M; Zairi F; Reyns N; Lejeune JP
Acta Neurochir (Wien); 2013 Aug; 155(8):1385-90; discussion 1390. PubMed ID: 23728501
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
Hammouche S; Clark S; Wong AH; Eldridge P; Farah JO
Acta Neurochir (Wien); 2014 Aug; 156(8):1475-81. PubMed ID: 24965072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]